Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-032703
Filing Date
2020-12-03
Accepted
2020-12-03 19:54:58
Documents
1
Period of Report
2020-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 22127
  Complete submission text file 0000899243-20-032703.txt   23652
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Issuer) CIK: 0001403752 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCOTHYREON INC. 2601 FOURTH AVE, SUITE 500 SEATTLE WA 98121
Business Address
HAUSMAN DIANA (Reporting) CIK: 0001563992 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38068 | Film No.: 201368265